House of Lords Business
Show full summary

Lord Moonie to ask Her Majesty's Government when they expect to receive a report from the National Institute for Clinical Excellence on the (1) efficacy, and (2) cost effectiveness, of the daratumumab treatment for myeloma; how long that evaluation has been in progress; and when this treatment is likely to be fully funded for the treatment of patients in the NHS.  HL15254

Question HL15254: tabled on 26 April 2021 and due for answer by 11 May 2021

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Moonie to ask Her Majesty's Government when they expect to receive a report from the National Institute for Clinical Excellence on the (1) efficacy, and (2) cost effectiveness, of the daratumumab treatment for myeloma; how long that evaluation has been in progress; and when this treatment is likely to be fully funded for the treatment of patients in the NHS.  HL15254
Legend for business item text
† Item that is new or altered.
[I] Indicates that the member concerned has a relevant registered interest.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Moonie
Non-affiliated
Life peer